DropGenie
Miniaturizes gene editing workflows to enable direct edits on primary patient cells for cell therapy and drug discovery
UndisclosedSeed+
Role not disclosedMG
Merck Global Health Innovation Fund
Activity from announced rounds
Activity in this selectionJun 30, 2026 · AI · Jun 1, 2026
Merck Global Health Innovation Fund is the US Merck/MSD investment fund identified in N-Power and Merck Digital Sciences Studio material.
Recorded funding activity
N-Power combines oncology care with trial-data services. DropGenie miniaturizes gene-editing workflows, while Infinimmune develops antibody medicines. The fund remains separate from the Merck parent and Germany’s Merck and M Ventures.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share